Skip to main content
Caplight Logo









Cartosense

Cartosense

Private
BangaloreHealthcare & Life Scienceshttps://cartosense.com

Last Round

Grant

Oct 1, 2024

Total Funding Raised

$110,000

Company Overview

Cartosense operates in Healthcare & Life Sciences and is based in Bangalore. Its latest recorded funding round was a Grant round in October 2024.

Cartosense is a surgical devices company that develops an augmented-reality-based software and hardware platform intended to enhance patient outcomes in targeted therapy and neurosurgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging, AR/VR Hardware

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Cartosense Comparables

Compare Cartosense with similar companies based on industry and business-model similarity.

Cartosense comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zeta Surgical
87%
Saphirex Surgicals
85%
SURGLASSES Inc.
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Cartosense Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 1, 2024
GrantNov 18, 2020
SeedApr 27, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Cartosense Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2024

    $60K grant from IKP Knowledge Park

  • Nov 18, 2020

    $10K grant from MedTech Innovator

Book a demo to see all signals

For institutional investors. Book with your work email.

Cartosense Filings

Explore SEC and related filing metadata, where available.

Cartosense filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Cartosense's valuation, stock price, and market status.

Is Cartosense a public or private company?

Cartosense is a private company.

What is the current stock price of Cartosense?

Cartosense is a private company, so its shares have no public market price. Caplight tracks Cartosense's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Cartosense worth (valuation)?

Valuation information for Cartosense is not publicly available.

Can I buy Cartosense stock?

Cartosense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Cartosense's last funding round?

Cartosense's most recent funding round was Grant on October 1, 2024.

Who are the main investors in Cartosense?

Key investors in Cartosense include IKP Knowledge Park, MedTech Innovator, Centre for Cellular and Molecular Platforms.

Will Cartosense IPO soon?

No public IPO plans have been announced for Cartosense.

How can I track Cartosense secondary market activity?

Caplight tracks bids, offers, and trades in Cartosense's shares on secondary markets.

Firmographic Details

HeadquartersBangalore
Employee Range4
Year Founded2017
Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?